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Particle rearrangements, compaction under pressure and in vitro dissolution have been evaluated after
melt dispersion of ibuprofen, Avicel and Aerosil. The Cooper–Eaton and Kuno equations were utilized
for the determination of particle rearrangement and compression behavior from tap density and
compact data. Particle rearrangement could be divided into two stages as primary and secondary
rearrangement. Transitional tapping between the stages was found to be 20–25 taps in ibuprofen
crystalline powder, which was increased up to 45 taps with all formulated powders. Compaction in the
rearrangement stages was increased in all the formulations with respect to pure ibuprofen. Signiﬁ-
cantly increased compaction of ibuprofen under pressure can be achieved using Avicel by melt
dispersion technique, which could be beneﬁcial in ibuprofen tablet manufacturing by direct compres-
sion. SEM, FTIR and DSC have been utilized for physicochemical characterization of the melt dispersion
powder materials. Dissolution of ibuprofen from compacted tablet of physical mixture and melt
dispersion particles has also been improved greatly in the following order: IbcoIbsmd1o Ibsmd2o
Ibsmp10o Ibsmd5o Ibsmd10.
& 2011 Elsevier B.V. All rights reserved.1. Introduction
In die compaction of powders, materials are subjected to
compressive forces, which lead to volume reduction and tablet
is produced. The volume reduction process is generally divided
into three different stages: (i) die ﬁlling, (ii) particle rearrange-
ment and (iii) deformation and bonding of discrete particles [1,2].
Particle rearrangement is the particle motion without deformation or
fracturing of the particles. It is a critical process for densiﬁcation
during the initial compression phase [2–6] at low applied pressures.
Rearrangement of particles becomes insigniﬁcant with increasing
pressure and the next phase proceeds by elastic deformation, plastic
ﬂow or fragmentation of the particles. The compression ability and
the dissolution rate of ibuprofen are poor and several efforts have
beenmade in past for their improvement. Crystal engineering [7] and
also spherical agglomeration [8] were developed for producing
directly compressible ibuprofen. There are many reports on solid
matrix systems prepared by melting or fusion [9–11] for speciﬁc
pharmaceutical processing and improvement of drug dissolution.
Hot-melt granules of drug (BAY 12-9566)—Gelucire 50/13—Neusilinll rights reserved.
x: þ91 674 2386271.
k).dispersion can be compressed easily into tablets with up to 30% w/w
drug loading [12]. Many reports are already published on techniques
of melt dispersion [13,14] andmelt solidiﬁcation [15,16] of ibuprofen.
Melt granulation technique was also adopted in ibuprofen tablet
formulations [17].
The present study has been explored to evaluate the particle
rearrangement under tapping and compression under applied
pressure of the hot-melt ibuprofen dispersion with Avicel con-
taining Aerosil and in vitro dissolution of the compact. Melt
dispersion powder mix has been tableted by direct compression,
which is supposed to bring about improvement in both mechanical
behavior and dissolution of drug. Cooper and Eaton [18] described
the compaction process of powders under applied pressure and
introduced a biexponential equation. This equation has also been
applied here in describing the densiﬁcation of powder under tapping
process. Kuno [19] developed his equation under tapping only to
describe the powder packing process. Kawakita and co-workers
[20,21] have described the densiﬁcation process both by tapping
and applied pressure. Therefore, the Cooper–Eaton compaction
parameters under tapping process could be of importance. Kuno
described the powder packing process and developed the equa-
tion based on the relationships between the change in apparent
density and the number of tappings. The early stage of compac-
tion process as a function of pressure due to slippage of particles
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literature although it is difﬁcult to characterize and quantify
[1,2,6,18,22,23]. An attempt has been made here to characterize
the early stages of compaction behavior by tapping process.
Characterization of particle rearrangements before deformation
and compression during deformation with increasing pressure
has been studied applying two different mathematical models,
namely Cooper–Eaton and Kuno. Physicochemical characteriza-
tion of the melt dispersion powder materials has also been carried
out by SEM, FTIR and DSC.2. Materials and methods
2.1. Preparation of powder materials by melt dispersion method
Ibuprofen (native crystalline powder: IOL Chemicals and
Pharmaceuticals Ltd., India), microcrystalline cellulose (Avicel
PH 101, average particle size 50 mm, mess size 60/200: Lupin
Pharmaceuticals, Mumbai, India) and colloidal silicone dioxide
(Aerosil 200, average particle size 15 nm: Lupin Pharmaceuticals,
Mumbai, India) were used in this study. Avicel has been lubri-
cated with Aerosil (1%, 2%, 5% and 10%) by simple blending using
mortar and spatula without triturating for 5 min and thereafter
named as Smcc1, Smcc2, Smcc5 and Smcc10, respectively.
In this process 5 g of ibuprofen was placed in a beaker for
45 min at 80 1C in an incubator. Each siliciﬁed sample was
incorporated into the completely melted ibuprofen and kneaded
for few minutes to a homogeneous mass. The mass was cooled to
laboratory ambient temperature and passed through mesh 30. In
this way four powdered samples were prepared and named as
Ibsmd1, Ibsmd2, Ibsmd5 and Ibsmd10 and preserved in screw cap
bottles. The formulation detail of melt dispersion ibuprofen
powder has been tabulated in Table 1.
2.2. Density measurement
Bulk density is the ratio of weight of powder to its volume
before tapping. The bulk density of powder is dependent on
particle packing. The bulk density was measured by pouring
powder sample into a graduated 50 ml cylinder (stoppered) and
the volume of the powder sample was recorded directly from the
cylinder. The measurement was repeated ﬁve times varying the
amount (15–20 g) and the value was reported. The tapped volume
was measured up to 200 taps using a bulk density measurementTable 1
Ibuprofen powder samples prepared by melt dispersion technique.
Powder
formulation
Aerosil added
to Avicela (%)
Ibc:Smcc
ratio
Technique used Aerosil in
ﬁnal mix (%)
Ibc – Crystalline
ibuprofen
alone
– –
Ibsmp10
b 10 (Smcc10) 1:1 Physical mixture 5.0
Ibsmd1
c 1 (Smcc1) 1:1 Melt dispersion 0.5
Ibsmd2
c 2 (Smcc2) 1:1 Melt dispersion 1.0
Ibsmd5
c 5 (Smcc5) 1:1 Melt dispersion 2.5
Ibsmd10
c 10 (Smcc10) 1:1 Melt dispersion 5.0
a Lubrication was done by physical mixing of Aerosil with Avicel (mcc) in a
mortar with spatula before use and named as Smcc.
b Prepared by blending crystalline ibuprofen and Smcc in a mortar with
spatula and not crushed.
c Kneaded mass was prepared after incorporating Smcc into the completely
melted ibuprofen (Ibc) at 80 1C and cooled to laboratory ambient temperature
and passed through mesh 30.apparatus (Koshiash Instruments bulk India) and the height of the
powder was determined visually. The true density was deter-
mined by helium pycnometer (Pycno 30, Smart Instruments,
India) without replication.
2.3. Compaction of powder
Ibuprofen pure and other formulated powders were com-
pacted on a hydraulic pellet press (Kimaya Engineers, India) over
a compression pressure ranging from 245 to 2942 MPa, using a
10 mm diameter die and ﬂat faced punches. Materials for each
pellet were weighed accurately (400 mg) and poured manually
into the die and pellets of each formulation were prepared.
Maximum upper punch pressure at each load with a dwelling
time of 60 s was recorded for compaction of each tablet in the
laboratory ambient condition (27 1C, 60% RH). The thickness
of each pellet was measured with a digital micrometer (Mitutoyo,
Japan). This data was used for the calculation of apparent density,
porosity and degree of volume reduction. Tablets were preserved
in a wide mouth tightly closed container immediately after
compression.
2.4. Characterization of particle rearrangement and
compression behavior
2.4.1. Application of Cooper–Eaton equation
Cooper and Eaton developed a biexponential equation for
describing the compaction of powders as a function of applied
pressure and adopted from other ﬁelds of industry for research in
pharmaceutical compression process. The equation is
ðð1=D0Þð1=DÞÞ=ðð1=D0Þ1Þ ¼ aexpðKa=PÞþbexpðKb=PÞ ð1Þ
where D0 and D are the relative density at zero pressure and at
pressure P, respectively, a indicates the fraction of the theoretical
maximal densiﬁcation, which could be achieved in the ﬁrst stage
by ﬁlling large voids by interparticulate slippage and b indicates
small voids by deformation or fragmentation at a higher pressure
in the second stage of densiﬁcation. Ka and Kb describe the
magnitude of pressure at which the respective compaction
process would occur with the greatest probability of density.
Tablets were produced on a hydraulic pellet press and the
parameters of the second stage due to particle deformation were
determined from the graphical plot of Ln((1/D0)(1/D))/(1/D0)1
versus 1/P, where the slope of the linear region is Kb and the
ordinate intercept of that linear region of the second stage
compaction measures (aþb).
Rearrangement of discrete particles could be described by two
major steps [24,25] based on cohesiveness of the powdered
material as (i) primary rearrangements of ﬁne discrete particles
and (ii) secondary rearrangements. Replacing pressure, P, by the
tapping number, N, in the Cooper–Eaton equation we get
ðð1=D0Þð1=DÞÞ=ðð1=D0Þ1Þ ¼ a1 expðK1=NÞþa2 expðK2=NÞ ð2Þ
where D0 and D are the relative density before tapping obtained
by poured density divided by equilibrium tapped density and the
relative density at Nth tapped obtained by apparent density of a
powder column divided by equilibrium tapped density, respec-
tively. The coefﬁcient K1 represents the tapping required to
induce densiﬁcation by primary particle rearrangements, which
has the greatest probability of density, whereas K2 represents
the tapping required to induce densiﬁcation through secondary
particle rearrangements. a1 and a2 are the dimensionless con-
stants that indicate the fraction of the theoretical maximum
densiﬁcation of tapping, which could be achieved by ﬁlling voids
by primary rearrangements (a1) and secondary rearrangements
(a2). Above parameters were determined from the graphical plot
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determined by the slopes of two linear regions, while a1 and
(a1þa2) determined from the ordinate intercepts of the linear
regions of initial and second stage of tapping, respectively.
2.4.2. Application of the Kuno equation
The relationship between the change in apparent density and
the number of tappings described by Kuno is
rt2rn ¼ ðrt2roÞexpð2KNÞ ð3Þ
where rt is the apparent density at equilibrium, rn the apparent
density at Nth tapped state, ro the apparent density at initial
cascade state and K the rate of packing process under tapping.
Eq. (3) can be rewritten as
rt2rn ¼ dexpð2KNÞ ð4Þ
lnðrt2rnÞ ¼D2KN ð5Þ
where ln d¼D
As the constant D is related to the process of particles
rearrangement by two major steps [24,25], the total rearrange-
ment phenomena can be described by the following biexponential
equation:
rt2rn ¼ d1 expð2KpNÞþd2 expð2KaNÞ ð6Þ
where d1¼(rpro) is the density difference that indicates the
primary rearrangements of ﬁne discrete particles, d2¼(rtrp)
the density difference due to secondary rearrangement process
followed by primary rearrangement, d1þd2¼rtro the density
difference that describes the total rearrangement phenomenon
that is the maximal compaction achieved after primary rearran-
gement of discrete particles and secondary rearrangement alto-
gether and Kp and Ka are the constants that give a measure of the
rate of packing during primary rearrangement and the rate of
packing during secondary rearrangement, respectively. Hence, the
packing of particle mass by primary rearrangement and second-
ary rearrangement could be expressed as
rt2rn ¼ ðrp2roÞexpð2KpNÞþðrt2rpÞexpð2KaNÞ ð7Þ
lnðrt2rnÞ ¼ lnðrp2roÞ2KpNþ lnðrt2rpÞ2KaN ð8Þ
where rp is the apparent density of powder column, which
describes the extent of primary rearrangement of discrete parti-
cles. The above constants were determined by biphasic linear
plots of ln(rtrn) versus N, where Kp and Ka were determined
from the slope of the ﬁrst and second linear regions, respectively,
and (d1þd2) and d2 were determined from ordinate intercepts of
these two linear regions.
The consolidation phenomenon on applied pressure can be
described by the same equation. After replacing the tapping
number, N, by pressure, P, the Kuno equation can be expressed as
rT2r¼ aexpð2KPÞ ð9Þ
lnðrT2rÞ ¼ lnðaÞ2KP ð10Þ
putting ln a¼A
lnðrT2rÞ ¼ A2KP ð11Þ
where rT is the true density and r is the apparent density at the
speciﬁc applied pressure P.
A is the constant obtained from ordinate intercept of the
graphical representation ln(rTr) versus P. The slope, K, repre-
sents the rate of packing under pressure or consolidation under
pressure. The intercept, A, is extrapolated from the linear part of
the Kuno plot. The constant A could be related to the process of
compaction by two major steps: (i) die ﬁlling and particle
rearrangement and (ii) particle deformation and bond formationof discrete particles:
rT2r¼ a1 expð2K1PÞþa2 expð2K2PÞ ð12Þ
where a1¼(rTrr) is the density difference that indicates the
theoretical maximal compaction, which could be achieved by die
ﬁlling and particle rearrangement, a2¼(rrro) the density dif-
ference due to plastic deformation and bond formation only and
K1 and K2 are the constants that give a measure of the rate of
packing during die ﬁlling and particle rearrangement and the rate
of packing during plastic deformation, respectively.
The biphasic equation can be expressed as
ðrT2rÞ ¼ ðrT2rrÞexpð2K1PÞþðrr2roÞexpð2K2PÞ ð13Þ
(rrro) and K2 were determined from the graphical plot of dense
compact of ln(rTr) versus P.
2.5. Characterization by differential scanning calorimetry (DSC),
Fourier transformed infrared (FTIR) spectroscopy and scanning
electron microscopy (SEM)
Differential scanning calorimetry (DSC) thermograms of the
formulated powdered products were recorded on a differential
scanning calorimeter (DSC Q10 V9.4 Build 287). Accurately
weighed samples (2–5 mg) were placed in sealed aluminum pans,
and scanned at a heating rate of 10 1C/min over the temperature
range of 20–170 1C using a nitrogen gas purge at 50 ml/min.
Fourier transformed infrared (FTIR) spectra of the powdered
samples were recorded using FTIR spectrometer (FTIR-4100typeA,
Jasco, Tokyo, Japan) employing the potassium bromide pellet
method. The samples were scanned from 4000 to 400 cm1. All
spectra were collected through the scan of accumulations 80 at a
resolution of 4 cm1 and scanning speed of 2 mm/s. Spectral
Manager for Windows software (Jasco, Tokyo, Japan) was used for
data acquisition and holding. The morphology of the particulate
samples was investigated using scanning electron microscopy
(SEM) (Instrument JSM-6390 Jeol, Japan). Samples were mounted
on carbon sticky tabs and sputtered with gold coating prior to
observations.
2.6. In vitro dissolution testing
In vitro drug release of the compressed tablets of all formula-
tions (Ibc, Ibsmp10, Ibsmd1, Ibsmd2, Ibsmd5 and Ibsmd10) was
performed using the rotating paddle method (900 ml phosphate
buffer of pH 7.2 as dissolution medium maintained at 3770.5 1C
and 50 rpm) with a Disso 2000 dissolution apparatus (Labindia,
India) and the dissolution was continued for 120 min. At pre-
determined time intervals, 5-ml samples were collected and then
replaced with an equal volume of dissolution medium. Collected
samples were then ﬁltered through a 0.45 mm membrane ﬁlter
(WHATMAN Puradisc 25 Nylon, India) and absorbance data were
recorded at 222 nm using UV–vis spectrophotometer (JASCO
V-630 spectrophotometer, Software: Spectra Manager). The mean
of four determinations was used to calculate the amount of drug
released from the samples using standard calibration curve and
the error expressed as standard deviation (mean7sd, n¼4).
2.7. Statistics
The analysis of variance (ANOVA) is a powerful resource that
can be used for analyzing the quality of the estimated regression
line. The total variation in the dependent variable was subdivided
into meaningful components that were then observed and treated
in a systematic manner. We had n experimental data points in the
usual form (xi, yi) and the regression line was estimated. In our
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Xn
i ¼ 1
ðyiyÞ2 ¼
Xn
i ¼ 1
ðy^iyÞþ
Xn
i ¼ 1
ðyiy^Þ
i.e. SST¼SSRþSSE, where SST is the total corrected sum of squares,
SSR the regression sum of squares and SSE the sum of squares of
residuals.
SSR reﬂects the amount of variation in the y-values explained
by the model, in this case the postulated straight line. The SSE
component reﬂects variation about the regression line. To test the
hypothesis, we computed
f ¼ SSR=1
SSE=ðn2Þ ¼
SSR
s2
and accepted Ho at a-level of signiﬁcance when fo fa (1, n2). It
is customary to refer to the various sums of squares divided by
their respective degrees of freedom as mean squares. When
the null hypothesis was accepted, that is when the computed
F-statistic did not exceed the critical value f0.05 (1, n2), we have
concluded that there was an insigniﬁcant amount of variation in
the response accounted for by the postulated model, the straight-
line function. If the F-statistic exceeds the critical value data will
not reﬂect sufﬁcient evidence to support the model postulated.Fig. 1. Cooper–Eaton plots of dense compact consolidated under pressure for me
maintained linearity (R240.91, and the null hypothesis was accepted). Proﬁles of ibu
comparative view.
Table 2
Cooper–Eaton compression parameters of the dense compacts of melt dispersion of ib
Powder formulation Compression pressure
range (MPa)
()Kb (MPa)
(mean7sd, n¼4)
(aþb
(mea
Ibc 245–2942 4.9570.781 0.978
Ibsmp10 245–2942 11.4471.076 0.975
Ibsmd1 245–2942 18.3671.161 0.950
Ibsmd2 245–2942 17.6171.890 0.944
Ibsmd5 245–2942 20.6171.989 0.944
Ibsmd10 245–2942 18.4571.155 0.951
Critical value f0.05 (1, n2) is more than 224; Insig¼ insigniﬁcant; Kb¼pressure at which
voids by deformation or fragmentation at higher pressure; (aþb)¼total fraction of the3. Results and discussion
3.1. Characteristics of particle applying Cooper–Eaton equation
Fig. 1 shows the Cooper–Eaton plots of dense compacts of four
representative melt dispersion powders (Ibsmd1, Ibsmd2, Ibsmd5
and Ibsmd10). The proﬁles of ibuprofen (Ibc) and physical mixture
(Ibsmp10) were included in the ﬁgure to get a comparative view.
The Cooper–Eaton model ﬁtted well to the data (R2¼0.911–0.969,
and null hypothesis was accepted) to produce dense compact in
the pressure range 245–2942 MPa. Values of the Cooper–Eaton
parameters of the dense compact are depicted in Table 2. Kb
determined from the slope improved in all the formulated melt
dispersions [17.61(71.890)–20.61(71.989) MPa] than the pure
drug (4.9570.781 MPa). This means the pressure required to
induce densiﬁcation by deformation [26] is more in the formu-
lated mixture than in ibuprofen alone.
Compaction can be completely explained by two separate
processes when the sum of a and b is equal to unity (1) [18].
This occurs by particle rearrangement and plastic ﬂow or frag-
mentation. If the sum of a and b is less than unity, other processes
must become operative before complete compaction is achieved.
The compaction process can be explained by the two aforemen-
tioned processes when the sum of a and b is equal to unity (1).
Compaction cannot be explained exclusively by these twolt dispersion powders (Ibsmd1, Ibsmd2, Ibsmd5 and Ibsmd10). All the proﬁles
profen (Ibc) and physical mixture (Ibsmp10) were included in the ﬁgure to get a
uprofen.
)
n7sd, n¼4)
R2 Computed
f¼SSR/s2
p Value
70.089 0.921 0.2 Insig
70.058 0.931 36.4 Insig
70.097 0.965 135.0 Insig
70.057 0.911 4.6 Insig
70.078 0.949 1.8 Insig
70.068 0.969 154.4 Insig
the theoretical maximal densiﬁcation achieved in the second stage by ﬁlling small
oretical densiﬁcation.
S. Mallick et al. / Results in Pharma Sciences 1 (2011) 1–10 5processes if the sum is less than unity, that is, there are other
processes present. The summation (aþb) yielded a value closer to
unity [from 0.947(70.085) to 1.035(70.095)] in all the cases,
which indicated that an almost unity packing fraction (nonporous
compact) could be obtained from all these powder mix of ibuprofen
in combination with Avicel/Aerosil or alone at studied pressure.
Particle rearrangements were described based on tapping
utilizing the Cooper–Eaton equation (2) in which the pressure,
P, was replaced in the Cooper–Eaton equation (1) by the tapping
number N. Fig. 2 exhibits the plot of Ln(1/D0)(1/D)/((1/D0)1)
versus 1/N of all samples of Ibsmd. Each proﬁle clearly depicted
the two distinct linear regions and was also found to ﬁt the
biexponential Cooper–Eaton equation (R2 values ranging from
0.909 to 0.995; null hypothesis was accepted). Rearrangement
parameters under tapping applying the Cooper–Eaton equation of
all the samples are tabulated in Table 3.Fig. 2. Plots of ln((1/D0)(1/D))/((1/D0)1) versus 1/N based on tapping for characte
Ibsmd5 and Ibsmd10). Two distinct linear regions (biexponential) (R
2 values 0.925–0.
indicate two major steps of particle rearrangement, namely (i) primary rearrangement of
Table 3
Particle rearrangements under tapping applying the Cooper–Eaton equation on the ba
Powder
formulation
Preliminary rearrangement Secondary rearrangem
() K1
(mean7sd,
n¼5)
a1 (mean7sd,
n¼5)
R2 () K2
(mean7sd,
n¼5)
a2 (m
n¼5
Ibc 2.28070.231 0.88870.061 0.927 3.94370.351 0.09
Ibsmp10 3.48070.353 0.52470.043 0.909 11.69671.031 0.42
Ibsmd1 5.58770.431 0.94370.078 0.928 6.89070.703 0.07
Ibsmd2 7.05470.338 0.96570.083 0.994 6.18970.440 0.05
Ibsmd5 4.22970.231 0.92070.079 0.991 9.32970.783 0.11
Ibsmd10 4.23370.430 0.97970.085 0.987 6.00670.541 0.05
Critical value f0.05 (1, n2) is more than 215 and for * more than 224; Insig¼ insigniﬁca
rearrangement and K2 is representative of the tapping required to induce densiﬁcation b
the fraction of the theoretical maximum densiﬁcation achieved by ﬁlling voids by prima
tapping of primary rearrangement and secondary rearrangement as per Cooper–Eaton m
basis of particle true density by total rearrangements via tapping process.The tappings required to induce densiﬁcation by primary particle
rearrangement (K1) and by secondary particle rearrangement (K2) are
improved in all the samples of melt dispersion powders [3.480
(70.353)–7.054(70.338) and 6.006(70.541)–11.696(71.031),
respectively] than ibuprofen alone [2.280(70.231) and 3.943
(70.351), respectively]. Maximum improvement has been
observed in primary rearrangement with Ibsmd2 (7.05470.338)
and secondary rearrangement with Ibsmd5 (9.32970.783). The
physical mixture (Ibsmp10) exhibited K1 and K2 values as
3.48070.353 and 11.69671.031, respectively. The fraction of
the theoretical maximum densiﬁcation achieved by ﬁlling voids
by primary rearrangement (a1) out of total rearrangements due to
tapping varied 0.524(70.043)–0.979(70.085) and by secondary
rearrangement (a2) due to tapping varied 0.054(70.00280)–
0.423(70.0431) in the powder samples. Therefore, densiﬁca-
tion by particle rearrangement proceeds mainly by primaryrization of particle rearrangements of melt dispersion powders (Ibsmd1, Ibsmd2,
994, and the null hypothesis was accepted) are identiﬁed in each proﬁle, which
ﬁne discrete particles and (ii) secondary rearrangement or agglomerate formation.
sis of equilibrium apparent density of ibuprofen samples of melt dispersion.
ent (a1þa2) Npc Computed
f¼SSR/s2
(1st line)
(2nd line)
p
Value
ean7sd,
)
R2
870.0083 0.922 0.98670.068 (0.56)* 20 (150.7)
(59.1)
Insig
370.0431 0.995 0.94770.085 (0.50)* 20–25 (183.4)
(5.5)
Insig
370.0061 0.976 1.01670.086 (0.43)* 20–30 (52.1)
(2.9)
Insig
670.0045 0.963 1.02070.083 (0.48)* 25–30 (4.6)
(3.6)
Insig
470.0201 0.964 1.03570.095 (0.41)* 40–45 (223.4)*
(2.9)
Insig
470.0028 0.986 1.03470.090 (0.37)* 35–40 (223.4)*
(1.8)
Insig
nt; K1 represents the tapping required to induce densiﬁcation by primary particle
y secondary particle rearrangement; a1, a2¼dimensionless constants that indicate
ry rearrangement (a1) and by secondary rearrangement (a2); Npc is the transitional
odel; * value in the parentheses indicates total packing fraction calculated on the
S. Mallick et al. / Results in Pharma Sciences 1 (2011) 1–106rearrangement process rather than the secondary one in all the
ibuprofen powders. The summation (a1þa2) produced a value
almost closer to unity [0.986(70.068)–1.035(70.095)] in all the
melt dispersion samples, which indicated that the total rearrange-
ments could be explained almost exclusively by these two steps
(primary and secondary rearrangements) and other processes were
absent. In the case of physical mixture (0.94770.085 for Ibsmp10)
other processes may become operative before complete rearrange-
ment is achieved. Total packing fraction by total rearrangements via
tapping process varied 0.37–0.56 calculated on the basis of particle
true density. This means 37–56% densiﬁcation could be possible by
rearrangements of the particles only as understood by tappingFig. 3. Kuno plots of ln(rtrn) versus N of melt dispersion powders (Ibsmd1, Ibsm
identiﬁed in each proﬁle with R2 values 0.903–0.996 and the null hypothesis was also
Table 4
Particle rearrangements under tapping applying Kuno equation of melt dispersion of i
Powder
formulation
()Kp102
(mean7sd, n¼5) (R2)
()Ka102
(mean7sd, n¼5) (R2)
(rpro) (rt
Ibc 3.72770.311 (0.959) 1.42570.181(0.983) 0.019 0.10
Ibsmp10 2.01770.158 (0.996) 0.54570.029(0.971) 0.103 0.15
Ibsmd1 3.81770.341 (0.962) 1.58070.0133(0.974) 0.101 0.77
Ibsmd2 4.77270.456 (0.990) 1.46370.152(0.980) 0.127 0.21
Ibsmd5 3.79370.326 (0.970) 2.33370.203(0.955) 0.023 0.17
Ibsmd10 5.01270.269 (0.983) 2.10770.231(0.985) 0.067 0.15
Critical value f0.05 (1, n2) is more than 224; Insig¼ insigniﬁcant; Kp and Ka are the cons
the rate of packing during secondary rearrangement, respectively, where (rpro) indi
(rtrp) is the density difference due to agglomerate formation only after achiev
rearrangement phenomena that is the maximal compaction achieved after primary re
apparent density of powder column that describes the extent of primary rearrangement
packing during primary rearrangement and the rate of packing during secondary rearran
and secondary rearrangement or agglomerate formation as per the Kuno equation.process based on the Cooper–Eaton equation without applying
pressure.
3.2. Characteristics of particle applying the Kuno equation
The Kuno plot of ln(rtrn) verses N of the melt dispersion
powders has been illustrated in Fig. 3 to describe the change in
densiﬁcation under tapping. Data of pure ibuprofen and physical
mixture (Ibsmp10) have also been presented in this ﬁgure. Two
distinct linear regions have been identiﬁed in each proﬁle and found
to ﬁt the biexponential Kuno equation (R2 values 0.955–0.996, and
null hypothesis was accepted). The rate of packing process of thed2, Ibsmd5 and Ibsmd10). Two distinct linear regions (biexponential) have been
accepted.
buprofen.
ro) (rtrp) rp Npk Computed f¼SSR/s2
(1st line)
(2nd line)
p Value
3 0.084 0.449(70.041) 25 (4.03)
(1.52)
Insig
0 0.047 0.640(70.043) 45 (3.44)
(2.08)
Insig
1 0.670 0.635(70.052) 40–45 (3.93)
(0.84)
Insig
4 0.087 0.689(70.059) 40–45 (3.45)
(0.86)
Insig
6 0.153 0.607(70.045) 35 (5.79)
(3.93)
Insig
1 0.084 0.603(70.058) 35 (4.16)
(0.54)
Insig
tants that give a measure of the rate of packing during primary rearrangement and
cates density difference due to primary rearrangements of ﬁne discrete particles,
ing primary rearrangement, (rtro) describes the density difference for total
arrangement of discrete particles and agglomerate formation altogether, rp is the
of discrete particles, (all in g/ml), Kp and Ka are the constants measuring the rate of
gement, respectively, and Npk is the transitional tapping of primary rearrangement
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rearrangement under tapping. Two major steps of particle rearran-
gement, namely (i) primary rearrangements of ﬁne discrete particles
and (ii) secondary rearrangements, can be explained as the two
rearrangement parameters. The rearrangement parameters of all the
samples applying the Kuno equation are tabulated in Table 4. The
rate of packing during primary rearrangement (Kp) and the rate of
packing during secondary rearrangements (Ka) have been improved
in all the samples of melt dispersion powders [from 3.793102
(70.326) to 5.012102(70.269) and from 1.463102
(70.152) to 2.333102(70.203), respectively] rather than that
in pure ibuprofen [between 3.727102(70.311) and 1.425
102(70.181), respectively]. The particle rearrangement was
described by Kuno to occur in two steps: (i) primary rearrangement
(ii) secondary rearrangement. Physical mixture (Ibsmp10) did not
show any improvement in neither of the primary and secondary
rearrangement processes [2.017102(70.158) and 0.545
102(70.029)]. Improvement is noticed in primary rearrangement
in the order Ibsmp10oIbcoIbsmd5oIbsmd1oIbsmd2oIbsmd10
and in secondary rearrangement in the order Ibsmp10oIbcoIbsmd2
oIbsmd1oIbsmd10oIbsmd5. Kawashima et al. [27] prepared
microspheres of ibuprofen and have shown the increased rate of
packing compared to that of original crystals of ibuprofen using the
Kuno equation. Density difference due to primary rearrangements of
ﬁne discrete particles (rpro) and that due to secondaryFig. 4. Plots of ln(rTr) versus P of the dense compact consolidated under pressure fo
samples in the graph show linear relationship (R2 values 0.901–0.982; the null hypoth
Table 5
Compression parameters of the dense compact applying the Kuno equation of melt dis
Powder
formulation
Compression
pressure range (MPa)
() K2103 (mean7sd,
n¼4) (R2)
(rTro)
Ibc 245–2942 0.22470.018 (0.981) 0.685
Ibsmp10 245–2942 0.22170.020 (0.977) 1.043
Ibsmd1 245–2942 0.15470.011 (0.908) 0.809
Ibsmd2 245–2942 0.22570.019 (0.907) 0.797
Ibsmd5 245–2942 0.24770.015 (0.901) 0.784
Ibsmd10 245–2942 0.19570.019 (0.940) 0.848
Critical value f0.05 (1, n2) is more than 224; Insig¼ insigniﬁcant; K2¼rate of packin
difference that indicates the theoretical maximal compaction which achieved by two ma
bond formation of discrete particle; (rTrr)¼density difference due to die ﬁlling and p
bond formation only; rr¼apparent density of powder column describes the extent ofrearrangement (rtrp) are more with the formulated powders than
the ibuprofen alone. Melt dispersion particles became more com-
pacted in the total rearrangement process (rtro) than that of pure
drug and physical mixture. Highest difference in density of (rtro)
was exhibited by Ibsmd1 (0.771 g/ml). Apparent density of powder
column that describes the extent of primary rearrangement (rp) of
discrete particles of melt dispersion and physical mixture varied in a
narrow range from 0.603 (70.058) to 0.689 (70.059) g/ml while
pure drug has shown poor value (0.44970.041 g/ml). Transitional
tapping between primary rearrangement and secondary rearrange-
ment of ibuprofen powder applying the Cooper–Eaton equation
(Npc) and the Kuno equation (Npk) occurred within 20–25 taps. The
same parameter increased with the formulated powders of melt
dispersion and found up to 40/45 taps applying two equations. The
values are reported in Tables 3 and 4.
Consolidation phenomenon of the dense compact produced
under pressure of all ibuprofen powder samples has also been
explained by plotting Ln(rTr) versus P replacing the tapping
number, N, by pressure, P, in the original Kuno equation and is
illustrated in Fig. 4 for melt dispersion materials. For all the powder
samples the graphs maintained practically linear and were found
to ﬁt to the linear relationship of the Kuno equation (R2 value
0.901–0.981, and null hypothesis was accepted) to produce dense
compact in the pressure range of 245–2942 MPa. The value of the
Kuno parameters of the dense compact are depicted in Table 5. Ther melt dispersion powders (Ibsmd1, Ibsmd2, Ibsmd5 and Ibsmd10). All the powder
esis was also accepted) to produce dense compact in the pressure range.
persion of ibuprofen.
(rrro) ( rTrr) rr (mean7sd, n¼4) Computed
f¼SSR/s2
p Value
0.044 0.641 0.47470.035 222.3 Insig
0.187 0.856 0.52870.041 193.7 Insig
0.152 0.656 0.70070.055 10.6 Insig
0.170 0.627 0.73270.051 28.6 Insig
0.189 0.595 0.77470.068 25.7 Insig
0.175 0.673 0.71170.049 22.5 Insig
g under pressure or consolidation during plastic deformation; (rTro)¼density
jor steps: (i) die ﬁlling and particle rearrangement and (ii) plastic deformation and
article rearrangement; (rrro)¼density difference due to plastic deformation and
die ﬁlling and particle rearrangement (density in g/ml).
Fig. 6. FTIR spectra of ibuprofen powder samples: Ibc shows characteristic peak of
ibuprofen at 1719 cm1 of high intensity due to carbonyl stretching. The absence
of major shift in the peak positions for physical mixture and melt agglomerate
(Ibsmp10, Ibsmd5 and Ibsmd10) suggested the absence of major interaction.
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not changed signiﬁcantly in the formulated powder compared to
pure ibuprofen powder. The density difference (rTro) indicated by
the process of compaction occurred (i.e. (i) die ﬁlling and particle
rearrangement and (ii) particle deformation and bonding of discrete
particles) has been increased in the formulation. Thus, by applying
the Kuno equation under pressure it may be understood that
increased compaction can be achieved both by lubrication with
Aerosil and by melt dispersion. Density difference due to die ﬁlling
and particle rearrangement (rTrr) actually dominated over plastic
deformation (rrro).
3.3. Scanning electron microscopy studies
The crystalline drug (Ibc) has a distinct geometric shape (Fig. 5A).
In the physical mixture (Ibsmp10) drug crystal surfaces are covered
by the Avicel/Aerosil particles and the crystals are almost not
affected (Fig. 5B). The melt dispersion particulate beads (Ibsmd10)
are of irregular shape with rough/porous surface (Fig. 5C and D). It
revealed that agglomerate has been produced during melt disper-
sion and size of the individual crystallite comprising the agglomer-
ate was also signiﬁcantly less than the individual crystal of pure
drug. This transformation of individual crystal of pure drug into
irregular porous/rough surfaced agglomerate of small crystallite is
the possible indication of partial amorphization.
3.4. FTIR studies
The FTIR spectrum of crystalline ibuprofen (Ibc) in Fig. 6 shows
the characteristic absorbance peak at 1719 cm1 with high intensity
due to carbonyl stretching. The absence of major shift in the peakFig. 5. Scanning electron micrographs of samples of ibuprofen crystals, physical mixtu
ibuprofen, magniﬁcation 500 ); (B) Ibsmp10 (ibuprofen crystals are identiﬁed in the physi
(magniﬁcation 1000 ) (in Ibsmd10 size of the individual crystallite comprising the agglopositions for melt agglomerate and physical mixture suggested
the absence of major interactions in the solid state between
Avicel/Aerosil and ibuprofen. Minor changes in shifting and intensity
of peak may be related to the amorphous transformation [28].
3.5. Differential scanning calorimetry studies
DSC thermograms of ibuprofen samples are presented in Fig. 7.
The DSC thermogram of crystalline ibuprofen (Ibc) showed are and melt dispersion powders. (A) Ibc (distinctive geometric shape of crystalline
cal mixture, magniﬁcation 500 ); (C) Ibsmd10 (magniﬁcation 500 ) and (D) Ibsmd10
merate was signiﬁcantly decreased than the individual crystal of pure drug).
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The thermograms of Ibsmp10, Ibsmd5 and Ibsmd10 show a gradual
decrease in melting endotherm at 75.6, 74.4 and 73.7 1C with
energies 59.2, 49.9 and 48.5 J/g, respectively, attributing to gradual
decrease in crystalline intensity of ibuprofen in the respective
samples. The ibuprofen melting onset temperature (74.4 1C) also
gradually decreased in the melt dispersion samples (73.7, 72.0 and
71.7 1C) due to the presence of drug in the matrix of Avicel/Aerosil.
DSC results might be an indication of maximum amorphization of
ibuprofen in Ibsmd10 [29].
3.6. In vitro dissolution studies
Fig. 8 shows dissolution patterns of ibuprofen from crystalline
drug (Ibc), physical mixture (Ibsmp10,) and melt dispersionFig. 8. Dissolution proﬁles of ibuprofen tablets (Ibc, Ibsmd1, Ibsmd2, Ibsmd5, Ibsmd
Fig. 7. DSC thermograms of ibuprofen powder samples (Ibc, Ibsmp10, Ibsmd5 and
Ibsmd10). Ibc melts at 76.59 1C. Gradual decrease in melting endotherm of
Ibsmp10, Ibsmd5 and Ibsmd10 has been observed at 75.64, 74.37 and 73.71 1C,
respectively.samples (Ibsmd1, Ibsmd2, Ibsmd5 and Ibsmd10). The dissolution
rate of pure ibuprofen was very low (37.179.9% and 45.573.5%
at 60 and 120 min, respectively). Poor dissolution of drug from
crystalline ibuprofen has already been reported by several
researchers earlier [30,31]. The dissolution rate was greatly
improved both in physical mixture and melt dispersion samples.
Presence of Avicel disintegrated the tablets very ﬁrstly. Moreover,
improved dissolution may be due to increased wettability and
increased amorphization of the drug. Presence of silicon dioxide
increased hydrophilicity of the drug particle and facilitated access
of water during dissolution. Maximum degree of wettability and
amorphization might have brought about by maximum concen-
tration of silicon dioxide in Ibsmd10 and improved dissolution
[28] to the maximum extent at 120 min (98.171.8%). The
dissolution of ibuprofen has been increased in the physical
mixture (77.273.2% in Ibsmp10) rather than the melt dispersion
samples of Ibsmd1 (70.273.2%) and Ibsmd2 (75.372.5%). Ibsmd5
has exhibited dissolution up to 89.171.98%. These improvements
in dissolution have also been reported previously when ibuprofen
was co-milled with silicon containing clay (kaolin) because of
amorphization of the drug [32].4. Conclusions
An attempt has been made for evaluation of particle rearran-
gement under tapping and consolidation by deformation and
fragmentation under applied pressure after melt dispersion of
ibuprofen, Avicel and Aerosil. The Cooper–Eaton and Kuno equa-
tions were applied for determination of both rearrangement and
compaction parameters under pressure from tap density and
compact data, respectively. The compressibility to induce densi-
ﬁcation by primary particle rearrangement and by secondary
particle rearrangement may be understood by tapping was
improved in all the samples of melt dispersion powders than
pure ibuprofen powder. Total packing fraction by particle rear-
rangement occurred up to 37–56%, calculated on the basis of
particle density via tapping process, which was mainly by
primary rearrangement process rather than the secondary one
in all the ibuprofen powders based on the Cooper–Eaton equation.
The rates of packing during both primary rearrangement and10 and Ibsmp10). Each data point represents the mean7sd of four repetitions.
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of melt dispersion powders compared to ibuprofen crystals based
on the biexponential Kuno equation. Transitional tapping
between primary and secondary rearrangement was 20–25 taps
with crystalline ibuprofen and the same increased up to 40–45
taps in the melt dispersion mixtures. Pressure required to achieve
densiﬁcation in the second stage by ﬁlling small voids by
deformation or fragmentation at a higher pressure was also more
in the formulated mixture than in ibuprofen alone. The densiﬁca-
tion achieved by ﬁlling large voids by interparticulate slippage
and small voids by deformation or fragmentation at a higher
pressure was operated simultaneously and an almost nonporous
compact was obtained from all the melt dispersion powder
samples of ibuprofen. The rate of packing process during die
ﬁlling and particle rearrangement and the rate of packing or
consolidation during plastic deformation did not change greatly
in the melt dispersion powder compared to ibuprofen crystals.
Increased compaction can be achieved after melt dispersion of
ibuprofen and silicon dioxide lubricated microcrystalline cellulose
than ibuprofen alone and could be utilized in the direct compres-
sion of ibuprofen tablet manufacturing. The dissolution of ibu-
profen has been greatly improved in the physical mixture and
melt dispersion particles than the crystalline drug. Increased
degree of siliciﬁcation improved both wettability and amorphiza-
tion of the drug, which brought about increased dissolution. The
degree of improvement in dissolution was found in the order of
Ibco Ibsmd1o Ibsmd2o Ibsmp10o Ibsmd5o Ibsmd10.
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